HSPC105 inhibitors are a class of small molecules that specifically target the HSPC105 protein, also known as nucleolar protein 14 (NOP14). This protein plays a role in cellular processes such as ribosome biogenesis, nucleolar structure, and cell cycle regulation. HSPC105 belongs to the heat shock protein (HSP) family, which are highly conserved proteins involved in various aspects of cellular homeostasis and response to stress. Inhibitors of HSPC105 are designed to interfere with the protein's normal function, affecting its ability to contribute to these cellular pathways. Structurally, these inhibitors often contain aromatic rings and side chains that allow for optimal binding to the active or allosteric sites of HSPC105. The chemical design of these inhibitors emphasizes high specificity to avoid off-target effects, focusing on chemical modifications that enhance binding affinity and stability within the cellular environment.
The mechanism of action for HSPC105 inhibitors generally involves binding to the protein's functional domains, thereby preventing its interaction with other proteins or nucleic acids critical to its role in ribosome production and cellular stress response. This interference can disrupt nucleolar organization and cellular growth, ultimately influencing cell cycle progression. The biochemical properties of HSPC105 inhibitors, such as their solubility, stability, and cell permeability, are crucial for their effectiveness in modulating protein function within different cellular compartments. Additionally, their synthesis involves considerations for optimizing pharmacokinetics and bioavailability within cells. This class of inhibitors is subject to extensive structure-activity relationship (SAR) studies to refine their interaction with HSPC105, aiming to enhance potency and specificity while reducing the likelihood of non-specific interactions with other cellular proteins. Overall, HSPC105 inhibitors are unique molecular tools for probing the biological roles of this protein within the context of cellular structure and regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit Kinetochore Scaffold 1 expression by interfering with RNA polymerase activity, leading to decreased transcription of Kinetochore Scaffold 1 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide could inhibit Kinetochore Scaffold 1 expression by blocking protein synthesis, thereby preventing the translation of Kinetochore Scaffold 1 mRNA into protein. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin might inhibit Kinetochore Scaffold 1 expression by prematurely terminating protein synthesis, leading to the degradation of partially translated Kinetochore Scaffold 1 mRNA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin may inhibit Kinetochore Scaffold 1 expression by blocking protein synthesis, similar to Cycloheximide, thus preventing the translation of Kinetochore Scaffold 1 mRNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin might inhibit Kinetochore Scaffold 1 expression by targeting bacterial RNA polymerase, which shares structural similarities with eukaryotic RNA polymerase, leading to decreased transcription of Kinetochore Scaffold 1 mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-Amanitin may inhibit Kinetochore Scaffold 1 expression by blocking RNA polymerase II activity, which is responsible for transcribing Kinetochore Scaffold 1 mRNA, thus preventing its synthesis. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine could inhibit Kinetochore Scaffold 1 expression by blocking protein synthesis, similar to Cycloheximide and Anisomycin, leading to the degradation of partially translated Kinetochore Scaffold 1 mRNA. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin might inhibit Kinetochore Scaffold 1 expression by interfering with protein glycosylation, which is necessary for the proper folding and stability of newly synthesized Kinetochore Scaffold 1 protein. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S could inhibit Kinetochore Scaffold 1 expression by causing premature termination of protein synthesis, leading to the degradation of partially translated Kinetochore Scaffold 1 mRNA. | ||||||